STANDING OVATION RAISES €12m TO DEVELOP ANIMAL-FREE DAIRY CHEESE

PUBLISHING DATE
September 20, 2022

French food technology start-up Standing Ovation has announced that it has raised €12 million in a series A round of investor funding to develop an animal-free casein for use in cheese.

According to the company, success would mean resulting cheese would technically qualify as dairy, but without any involvement of animals, so it would still be vegan.

The financing round is being led by Astanor Ventures, with the participation of Peakbridge, Seventure Partners, Big Idea Ventures, Good Startup, as well as other leading players in the food industry.

This round, completed less than two years after its creation, will be used to finance the next phase in the company’s development and scale its technology to meet industrial demand, the company said.

Global protein demand, and animal protein in particular, is increasingly dramatically with a rapidly growing global population and global diets shifting towards animal‐based products. Yet livestock farming today represents 15% of greenhouse gas emissions and intensive livestock farming is considered unethical by a growing number of people.

Casein is a protein found in dairy products, and which constitutes around 80% of cow milk. It is the ingredient responsible for cheese’s nutrients, smell and texture. According to Standing Ovation, this is the only ingredient found in cheese made by the cow.

Standing Ovation says that its ambition is to contribute to the agri-food transition by developing animal and lactose‐free substitutes for cheese and dairy products, using dairy proteins produced by microbial fermentation. Thanks to a simple but innovative process, the company produces caseins, without any recourse to animal products. Caseins are not only the major proteins in milk (over 80%), but also the proteins that allow it to curdle and give cheese its functional melting and stretching characteristics customers are craving.

The company claims to have demonstrated that these caseins can then be used, with other products of vegetal or mineral origin, to obtain true replicas of cheese products, with a focus on fresh and soft cheeses.

The round, initially planned for a total of €10m, but oversubscribed up to €12m, will enable the company to finance its growth, and in particular to bring casein production process to industrial scale, to perfect its products and to initiate the regulatory process, while continuing to develop its R&D activity to create new products and formulations, the company said.

Frederic Paques, CEO of Standing Ovation, commented: “Standing Ovation’s technology has a tremendous potential. However, bringing the products rapidly to the market requires significant resources, and substantial funding had become necessary. Astanor Ventures, which had already supported us at an earlier stage, understood it as did the other participants in this round. We would like to thank all our investor partners for their support and their confidence in the team.”

Romain Chayot, Scientific Director of Standing Ovation, went on: “In only two years, we have developed a unique and highly technological process. We are now in a strong position to build on this momentum and transition towards more logistically intensive stages, especially scaling up.”

Eric Archambeau, co‐founder of Astanor Ventures, added: “Standing Ovation’s technology represents a paradigm shift for the animal‐free dairy market. Casein is the holy grail for the production of alternative options that match conventional products in nutrition, taste and texture yet it has remained notoriously difficult to create. The founders’ experience in biotechnology enabled them to find the key to casein development, a step ahead of many companies. We are greatly impressed by the team’s advancements over the past year both in product and process development and are excited to support them in this next step of their journey.”

About Standing Ovation

Created in 2020 and based in Paris, Standing Ovation aims to become a key player in the food transition. The company develops the production of caseins by precision fermentation and their transformation into non‐animal and lactose‐free substitutes for cheese and dairy products.

For more dairy news, click here


Join us at SIAL Paris as exhibitor Join us at SIAL Paris as visitor